Cargando…

The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment

SIMPLE SUMMARY: The unique characteristics of tumor energy metabolism (highly dependent on aerobic glycolysis, namely, the Warburg effect) make it an interesting and attractive target for drug discovery. Radio- and chemoresistance are closely associated with the Warburg effect. Lonidamine (LND), as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yaxin, Sun, Guohui, Sun, Xiaodong, Li, Feifan, Zhao, Lijiao, Zhong, Rugang, Peng, Yongzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696079/ https://www.ncbi.nlm.nih.gov/pubmed/33187214 http://dx.doi.org/10.3390/cancers12113332

Ejemplares similares

Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
por: Fan, Tengjiao, et al.
Publicado: (2019)

Quantitative Structure-Activity Relationship (QSAR) Studies on the Toxic Effects of Nitroaromatic Compounds (NACs): A Systematic Review
por: Huang, Tao, et al.
Publicado: (2021)

In Silico Prediction of O(6)-Methylguanine-DNA Methyltransferase Inhibitory Potency of Base Analogs with QSAR and Machine Learning Methods
por: Sun, Guohui, et al.
Publicado: (2018)

Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies
por: Zhou, Yue, et al.
Publicado: (2018)

Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking
por: Sun, Guohui, et al.
Publicado: (2016)

Inhibition of the recovery from potentially lethal damage by lonidamine.
por: Hahn, G. M., et al.
Publicado: (1984)

Influence of the Expression Level of O(6)-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry
por: Li, Lili, et al.
Publicado: (2015)

Metabolic Activation and Carcinogenesis of Tobacco-Specific Nitrosamine N’-Nitrosonornicotine (NNN): A Density Function Theory and Molecular Docking Study
por: Fan, Tengjiao, et al.
Publicado: (2019)

QSAR and Classification Study on Prediction of Acute Oral Toxicity of N-Nitroso Compounds
por: Fan, Tengjiao, et al.
Publicado: (2018)

Discovering a Reversible Male Contraceptive Agent Derived from Lonidamine
por: Gong, Shengnan, et al.
Publicado: (2023)

Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021)

Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles
por: Li, Huizhen, et al.
Publicado: (2022)

Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
por: Chen, Chen, et al.
Publicado: (2022)

Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
por: Silvestrini, B., et al.
Publicado: (1983)

Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
por: Cervantes-Madrid, Diana, et al.
Publicado: (2015)

Phase II study of lonidamine in metastatic breast cancer.
por: Pronzato, P., et al.
Publicado: (1989)

Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation
por: Xiao, Weinan, et al.
Publicado: (2019)

Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis
por: Zhou, Yue, et al.
Publicado: (2017)

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019)

Effect of lonidamine derivatives on the inhibition of transformed cell area expansion
por: Aoyama, Megumi, et al.
Publicado: (2023)

Identification of Pharmacophoric Fragments of DYRK1A Inhibitors Using Machine Learning Classification Models
por: Bi, Mengzhou, et al.
Publicado: (2022)

A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea
por: Li, Duo, et al.
Publicado: (2023)

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
por: De Cesare, M., et al.
Publicado: (1998)

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
por: Shutkov, Ilya A., et al.
Publicado: (2023)

Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance
por: Chen, Enping, et al.
Publicado: (2021)

LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions
por: Rochani, Ankit Kanaiyalal, et al.
Publicado: (2020)

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.
por: Citro, G., et al.
Publicado: (1991)

Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
por: Bhutia, Yangzom D., et al.
Publicado: (2016)

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018)

Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020)

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016)

Phase II study of lonidamine in non-small cell lung cancer: final report.
por: Kokron, O., et al.
Publicado: (1990)

A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
por: Mansi, J. L., et al.
Publicado: (1991)

In vitro effects of lonidamine and 6-aminonicotinamide against Echinococcus granulosussensu stricto and Echinococcus multilocularis
por: Xin, Qi, et al.
Publicado: (2020)

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease
por: Sundar, Shirin V., et al.
Publicado: (2022)

Lonidamine and domperidone inhibit expansion of transformed cell areas by modulating motility of surrounding nontransformed cells
por: Aoyama, Megumi, et al.
Publicado: (2022)

pH-dependent structural characteristics of lonidamine: (1)H and (13)C NMR study
por: Gupta, Pradeep Kumar, et al.
Publicado: (2023)

Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer
por: Wang, Zhongjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_47ipbm3k6tc77ontu8a97j2kha